Patents by Inventor Silvia Trasciatti

Silvia Trasciatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteogenic growth oligopeptides as stimulants of hematopoiesis
    Publication number: 20050004037
    Abstract: The present invention relates to a pharmaceutical composition comprising as an effective ingredient an oligopeptide identical or analogous to the C-terminal portion of OGP, having stimulatory activity on the production of hematopoietic cells. Preferred oligopeptides that are used are Tyr-Gly-Phe-Gly-Gly, Tyr-Gly-Phe-His-Gly, Gly-Phe-Gly-Gly or Met-Tyr-Gly-Phe-Gly-Gly. More specifically, these oligopeptides enhance the engraftment of bone marrow transplants, hemopoietic reconstruction, bone marrow re-population and peripheral stem cell mobilization, preferably after chemotherapy or irradiation. The invention further provides methods of treatment and for using these oligopeptides in the preparation of pharmaceutical compositions.
    Type: Application
    Filed: January 29, 2004
    Publication date: January 6, 2005
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Itai Bab, Michael Chorev, Arye Shteyer, Andras Muhlrad, Nura Mansur, Olga Gurevitch, Zvi Greenberg, Sergio Rosini, Silvia Trasciatti, Mario Petrini
  • Catalytic monoclonal antibodies with protease activity for selective lysis of protein component of plaques aggregates pathological conditions
    Patent number: 6387674
    Abstract: Catalytic monoclonal antibodies (abzymes) with selective protease activity in the pathologies characterized by the presence of plaques and fibrillar aggregates with protein component; methods for the preparation thereof and the use thereof as medicaments in the treatment of pathologies such as Alzheimer's disease, amyloidosis, atherosclerosis, prions diseases.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: May 14, 2002
    Assignee: Abiogen Pharma S.p.A.
    Inventors: Silvia Trasciatti, Sergio Rosini